The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus
Abstract
BACKGROUND: Medication nonadherence may reduce the effectiveness of therapies. To our knowledge, the association between medication nonadherence and mortality remains unexplored outside the context of clinical trials. METHODS: A retrospective cohort study of 11 532 patients with diabetes mellitus in a managed care organization. Medication adherence was calculated as the proportion of days covered for filled prescriptions of oral hypoglycemics, antihypertensives, and statin medications. The primary outcomes of interest were all-cause hospitalization and all-cause mortality. Multivariable regression analyses were performed to assess the independent association between medication adherence and outcomes. RESULTS: Nonadherent patients (proportion of days covered, <80%; prevalence, 21.3%) were younger and had fewer comorbidities compared with adherent patients. During follow-up, nonadherent patients had higher glycosylated hemoglobin, systolic and diastolic blood pressure, and low-density lipoprotein cholesterol levels. In unadjusted analyses, nonadherent patients had higher all-cause hospitalization (23.2% vs 19.2%, P<.001) and higher all-cause mortality (5.9% vs 4.0%, P<.001). In multivariable analyses, medication nonadherence remained significantly associated with increased risks for all-cause hospitalization (odds ratio, 1.58; 95% confidence interval, 1.38-1.81; P<.001) and for all-cause mortality (odds ratio, 1.81; 95% confidence interval, 1.46-2.23; P<.001). The findings were consistent across patient subgroups and using different cutoffs for the proportion of days covered. CONCLUSIONS: Medication nonadherence is prevalent among patients with diabetes mellitus and is associated with adverse outcomes. Interventions are needed to increase medication adherence so that patients can realize the full benefit of prescribed therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonadherence in T2D is independently associated with poor glycemic control, increased rates of vascular, renal, and other complications, and mortality [7, 8, 11].”
From Positive Psychological Interventions for Patients with Type 2 Diabetes: Rationale, Theoretical Model, and Intervention Development (2015) · cites this paper as [7]
In the citing paper
“Most patients with type 2 diabetes (T2D) have suboptimal adherence to recommended diet, physical activity, and/or medication.”
From Positive Psychological Interventions for Patients with Type 2 Diabetes: Rationale, Theoretical Model, and Intervention Development (2015) · cites this paper as [7]
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Adherence to Long-Term Therapies: Evidence for Action
Geest, S. D., & Sabate, E. J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,310
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F. L., Powe, N. R., & Golden, S. H. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00007 · Cited by 1,657
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
A Nanotechnological Approach to the Management of Alzheimer Disease and Type 2 Diabetes
Alam, Q., ZubairAlam, M., Karim, S., Gan, S. H., Kamal, M. A., Jiman-Fatani, A. A., Damanhouri, G., Abuzenadah, A. M., Chaudhary, A., & Haque, A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660159 · Cited by 19
Abegaz, T. M., Sori, L. M., & Toleha, H. N. (2017) · Psychiatry Journal · doi:10.1155/2017/5812817 · Cited by 19
Mitiku, Y., Belayneh, A., Tegegne, B. A., Kebede, B., Abebe, D., Biyazin, Y., Tefera, B. B., Abebaw, A., Getachew, M., & Mengist, H. M. (2022) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v32i4.12 · Cited by 20
Wu, J., Shen, J., Tao, Z., Song, Z., & Chen, Z. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s382362 · Cited by 19
Jayawardena, R., Kodithuwakku, W., & Sooriyaarachchi, P. (2023) · Dialogues in Health · doi:10.1016/j.dialog.2023.100137 · Cited by 14
Diabetes Mellitus—Digital Solutions to Improve Medication Adherence: Scoping Review
Georgieva, N., Tenev, V., Kamusheva, M., & Petrova, G. I. (2023) · Diabetology · doi:10.3390/diabetology4040040 · Cited by 19
Bosl, W. J., Mandel, J. C., Jonikas, M. A., Ramoni, R. B., Kohane, I. S., & Mandl, K. D. (2013) · Interactive Journal of Medical Research · doi:10.2196/ijmr.2480 · Cited by 19
Disease Management and Medication Compliance
Cohen, J., Christensen, K., & Feldman, L. (2011) · Population Health Management · doi:10.1089/pop.2011.0020 · Cited by 19
Pharmacy Effect on Adherence to Antidiabetic Medications
Sharma, K. P., & Taylor, T. N. (2012) · Medical Care · doi:10.1097/mlr.0b013e318249d800 · Cited by 19
Jing, S., NALIBOFF, A. R., Kaufman, M. B., & Choy, M. (2011) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2011.17.5.355 · Cited by 19
Risk for Cost‐related Medication Nonadherence Among Emergency Department Patients
Mazer-Amirshahi, M. E., Bisgaier, J., Dailey, E. A., Srivastava, K., McDermoth, M., Datner, E. M., & Rhodes, K. V. (2011) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2011.01007.x · Cited by 19
Yang, Y., Thumula, V., Pace, P. F., Banahan, B. F., Wilkin, N. E., & Lobb, W. B. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1242-z · Cited by 19
Impact of Obtaining Medications from Pharmaceutical Company Assistance Programs on Therapeutic Goals
Trompeter, J. M., & Havrda, D. E. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l420 · Cited by 19
Impact of workplace health services on adherence to chronic medications.
Sherman, B. W., Frazee, S. G., Fabius, R. J., Broome, R. A., Manfred, J., & Davis, J. (2009) · PubMed · Cited by 18
Griffin, T. P., Wall, D., Browne, G. A., Dennedy, M. C., & O’Shea, P. M. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217728964 · Cited by 21
Prescription fill rates for acute and chronic medications in claims-EMR linked data
Park, Y., Yang, H., Das, A. K., & Yuen-Reed, G. (2018) · Medicine · doi:10.1097/md.0000000000013110 · Cited by 19
Marušić, S., Meliš, P., Lucijanić, M., Grgurević, I., Turčić, P., Neto, P. R. O., & Bilić-Čurčić, I. (2018) · Croatian Medical Journal · doi:10.3325/cmj.2018.59.290 · Cited by 19
Oral antidiabetic drug use and associated health outcomes in cancer patients
Tan, X., Feng, X., Chang, J. T., Higa, G. M., Wang, L., & LESLIE, D. L. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12430 · Cited by 19
Nepalese patients’ anti-diabetic medication taking behaviour: an exploratory study
Sapkota, S., Brien, J.-A. E., & Aslani, P. (2017) · Ethnicity and Health · doi:10.1080/13557858.2017.1294659 · Cited by 18
Kalra, S., Das, A. K., Baruah, M. P., Unnikrishnan, A., Dasgupta, A., Shah, P., Sahay, R. K., Shukla, R., Das, S., TIWASKAR, M. H., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0651-1 · Cited by 18
Abebe, A., Wondimhunegn, Y. W., Kebede, B., Wale, A., Destaw, A., & Ambaye, A. S. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-00995-4 · Cited by 22
Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence?
Kocarnik, B. M., Liu, C., Wong, E. S., Perkins, M. W., Maciejewski, M. L., Yano, E. M., Au, D. H., Piette, J. D., & Bryson, C. L. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-391 · Cited by 21
Blackburn, D. F., Evans, C. D., Eurich, D. T., Mansell, K. D., Jorgenson, D. J., Taylor, J., Semchuk, W., Shevchuk, Y. M., Rémillard, A. J., Tran, D. A., et al. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1831 · Cited by 18
Shin, W. Y., Kim, H. C., Lee, T., Jeon, D.-H., Ha, K. H., Kim, D. J., & Chang, H. (2018) · Diabetic Medicine · doi:10.1111/dme.13695 · Cited by 18
Stämpfli, D., Boeni, F., Gerber, A., Bättig, V. A. D., Weidmann, R., Hersberger, K. E., & Lampert, M. L. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021284 · Cited by 18
Charlton, A., Vidal, X., Sabaté, M., Bailarín, E., Leguízamo-Martínez, L. M., & Ibáñez, L. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.9.1210 · Cited by 18
Polinski, J. M., Schneeweiß, S., Glynn, R. J., Lii, J., & Rassen, J. A. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3250 · Cited by 18
Novel incentive-based approaches to adherence
Kimmel, S. E., & Troxel, A. B. (2012) · Clinical Trials · doi:10.1177/1740774512453520 · Cited by 18
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
Chan, W. B., Chen, J.-F., Goh, S., Vũ, T. T. H., Isip-Tan, I. T., Mudjanarko, S. W., Bajpai, S., Mabunay, M. A., & Bunnag, P. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s143046 · Cited by 18
Treatment and Control of BP and Lipids in Patients with Hypertension and Additional Risk Factors
Welch, V. L. L., & Tang, S. S. K. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707050-00008 · Cited by 18
Fraser, S. D., Stannard, S., Holland, E., Boniface, M., Hoyle, R. B., Wilkinson, R., Akbari, A., Ashworth, M. J., Berrington, A. M., Chiovoloni, R., et al. (2023) · Journal of Multimorbidity and Comorbidity · doi:10.1177/26335565231204544 · Cited by 16
The role of emotion dysregulation in self-management behaviors among adults with type 2 diabetes
Kollin, S. R., Gratz, K. L., & Lee, A. A. (2024) · Journal of Behavioral Medicine · doi:10.1007/s10865-024-00483-5 · Cited by 20
Masuda, K., Aoki, K., & Terauchi, Y. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00129.x · Cited by 17
Doggrell, S. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03137.x · Cited by 17
Predictors of Medication Adherence in an Urban Latino Community with Healthcare Disparities
Colby, J. A., Wang, F., Chhabra, J., & Pérez‐Escamilla, R. (2011) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-011-9545-7 · Cited by 17
Beltrán, S., Lett, E., & Cronholm, P. F. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.06.005 · Cited by 17
Improving Adherence in Type 2 Diabetes.
Swe, K., & Reddy, S. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.007 · Cited by 16
Harbig, P., Barat, I., Nielsen, P. L., & Damsgaard, E. M. S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2351 · Cited by 17
Patient Complexity and Risk Factor Control Among Multimorbid Patients With Type 2 Diabetes
Malik, S., Billimek, J., Greenfield, S., Sorkin, D. H., Ngo‐Metzger, Q., & Kaplan, S. H. (2012) · Medical Care · doi:10.1097/mlr.0b013e318273119b · Cited by 17
Yang, Y., Thumula, V., Pace, P. F., Banahan, B. F., Wilkin, N. E., & Lobb, W. B. (2010) · Journal of the American Pharmacists Association · doi:10.1331/japha.2010.09071 · Cited by 17
Appraisal of Perceived Threat of Diabetes and the Relation to Adherence for Adults in Appalachia
Carpenter, R. D. (2012) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2012.0049 · Cited by 17
Grover, A., Rehan, H. S., Gupta, L. K., & Yadav, M. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.07.007 · Cited by 17
Novel Type 2 Diabetes Medication Access and Effect of Patient Cost Sharing
Henk, H. J., Lopez, J. M. S., & Bookhart, B. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.9.847 · Cited by 17
Pednekar, P. P., Heller, D. A., & Peterson, A. M. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.9.1099 · Cited by 18
HIGHTON, P. J., Funnell, M. P., Gupta, P., Zaccardi, F., Lim, L., Seidu, S., & Khunti, K. (2025) · Diabetologia · doi:10.1007/s00125-025-06617-x · Cited by 26
Schwartz, J. K., Grogan, K. A., Mutch, M. J., Nowicki, E. B., Seidel, E. A., Woelfel, S. A., & Smith, R. O. (2017) · American Journal of Occupational Therapy · doi:10.5014/ajot.2017.021691 · Cited by 16
Ofori‐Asenso, R., Liew, D., Lalic, S., Mazidi, M., Magliano, D. J., Ademi, Z., Bell, J. S., & Ilomäki, J. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01077-3 · Cited by 18
Katakami, N., Mita, T., Yoshii, H., Shiraiwa, T., Yasuda, T., Okada, Y., Torimoto, K., Umayahara, Y., Kaneto, H., Osonoi, T., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01125-8 · Cited by 16
Habib, B., Buckeridge, D. L., Bustillo, M., Marquez, S. N., Thakur, M., Tran, T., Weir, D. L., & Tamblyn, R. M. (2021) · JAMIA Open · doi:10.1093/jamiaopen/ooab050 · Cited by 18
Acharya, M., Ali, M. M., BOGULSKI, C. A., Pandit, A. A., Mahashabde, R. V., Eswaran, H., & Hayes, C. J. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08511-x · Cited by 17
Medication adherence among patients in a chronic disease clinic
Tourkmani, A. M., Albabtain, M. A., & Bakhiet, A. (2012) · Saudi Medical Journal · doi:10.15537/1658-3175.5667 · Cited by 16
Medication adherence issues in patients: focus on cost
Matsui, D. M. (2013) · Clinical Audit · doi:10.2147/ca.s30125 · Cited by 16
Interventions aimed at improving performance on medication adherence metrics
McGinnis, B., Kauffman, Y. S., Olson, K. L., Witt, D. M., & Raebel, M. A. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9872-y · Cited by 16
Adherence to Oral Diabetes Medications Among Users and Nonusers of Antipsychotic Medication
Desai, P. R., Adeyemi, A., Richards, K. M., & Lawson, K. A. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201300118 · Cited by 16
Volino, L. R., Das, R. P., Mansukhani, R. P., & Cosler, L. E. (2014) · American Journal of Pharmaceutical Education · doi:10.5688/ajpe789169 · Cited by 16
Ta, J. T., Erickson, S. C., Qiu, W., & Patel, B. V. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.7.787 · Cited by 16
Garcia, M. L., Castañeda, S. F., Allison, M., Elder, J. P., & Talavera, G. A. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.04.007 · Cited by 18
Summers, C., & Curtis, K. (2020) · JMIR Diabetes · doi:10.2196/15030 · Cited by 16
Long, J. A., Ganetsky, V. S., Canamucio, A., Dicks, T. N., Heisler, M., & Marcus, S. C. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.16369 · Cited by 16
Tunceli, K., Iglay, K., Zhao, C., Brodovicz, K. G., & Radican, L. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.031 · Cited by 16
Evaluation of Adherence to Diabetic Treatment in Northern Region of United Arab Emirates
Koprulu, F., Bader, R., Hassan, N., Abduelkarem, A. R., & Mahmood, D. (2014) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v13i6.24 · Cited by 16
The impact of medication-focused workshops in a diabetes educational program in jail: a pilot study
Davoust, S., Ghaleb, V., Guillon, S., Amirat-Combralier, V., Bartoli, C., & Hache, G. (2015) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-015-0238-5 · Cited by 16
Laiteerapong, N., John, P. M., Meltzer, D. O., & Huang, E. S. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1951-y · Cited by 15
Perceptions of Generic Drug Discount Programs Among Low-Income Women: A Qualitative Study
Omojasola, A., Gor, B., & Jones, L. A. (2012) · Women s Health Issues · doi:10.1016/j.whi.2012.10.002 · Cited by 15
Heflin, C. M., Hodges, L. B., Ojinnaka, C. O., & Arteaga, I. A. (2021) · Journal of Applied Gerontology · doi:10.1177/07334648211022493 · Cited by 15
Stone, J. Y., Mayberry, L. S., Clouse, K., & Mulvaney, S. A. (2023) · Current Diabetes Reports · doi:10.1007/s11892-023-01499-y · Cited by 17
de Bruin, T. W., Reele, S. B., Hamer-Maansson, J. E., Parikh, S. J., & Tang, W. (2015) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.220 · Cited by 15
Mabotuwana, T., & Warren, J. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2009.08.012 · Cited by 15
A randomized controlled trial of negative co-payments: the CHORD trial.
Kg, V., Troxel, A. B., Ja, L., Ibrahim, S. A., Appleby, D., Smith, J. O., Jaskowiak, J., Helweg‐Larsen, M., Ja, D., & Se, K. (2015) · PubMed · Cited by 15
Sodihardjo, F., van Dijk, L., Wensing, M., Smet, P. A. G. M. D., & Teichert, M. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2149-3 · Cited by 15
Jiang, R., Law, E. H., Zhou, Z., Yang, H., Wu, E. Q., & Seifeldin, R. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0410-8 · Cited by 16
Relationship between loneliness and blood glucose control in diabetes
Kobos, E., Szewczyk, A., Świątkowska, T., Kryczka, T., & Sienkiewicz, Z. (2020) · BMC Public Health · doi:10.1186/s12889-020-09241-z · Cited by 15
Berger, J. E. (2007) · PubMed · Cited by 15
Hong, J.-S., & Kang, H.-C. (2010) · Health Policy and Management · doi:10.4332/kjhpa.2010.20.2.128 · Cited by 15
Two character traits associated with adherence to long term therapies
Reach, G. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.06.008 · Cited by 15
Effects of a Patient Education Support Program on Pramlintide Adherence
Lorenzi, G. M., LaRue, S. M., & Collins, S. E. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.1.17 · Cited by 15
Garcia, B. H., Storli, S. L., & Småbrekke, L. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-197 · Cited by 16
Raebel, M. A., Dyer, W., Nichols, G. A., Goodrich, G. K., & Schmittdiel, J. A. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1994 · Cited by 15
Uncontrolled diabetes and health care utilisation: panel data evidence from Spain
Gil, J., Sicras‐Mainar, A., & Zucchelli, E. (2017) · The European Journal of Health Economics · doi:10.1007/s10198-017-0920-8 · Cited by 15
Shafrin, J. T., Bognar, K., Everson, K., Brauer, M., Lakdawalla, D. N., & Forma, F. M. (2018) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s175877 · Cited by 15
Vluggen, S., Hoving, C., Schaper, N. C., & de Vries, H. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.10.002 · Cited by 15
Qin, X. S., Hung, J., Knuiman, M. W., Briffa, T. G., Teng, T. K., & Sanfilippo, F. M. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4939 · Cited by 15
Kharrazi, H., Ma, X., Chang, H.-Y., Richards, T., & Jung, C. (2021) · Population health management · doi:10.1089/pop.2020.0306 · Cited by 11
Dalal, M. R., Kazemi, M. R., & Ye, F. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1248911 · Cited by 14
Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study
Hempenius, M., Rijken, S., Groenwold, R. H. H., Hek, K., de Boer, A., Klungel, O. H., & Gardarsdóttir, H. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15472 · Cited by 13
Belachew, E. A., Netere, A. K., & Sendekie, A. K. (2022) · Asthma Research and Practice · doi:10.1186/s40733-022-00089-1 · Cited by 14
Optimizing outcomes for GLP-1 agonists.
Freeman, J. S. (2011) · PubMed · Cited by 14
Leiter, L. A., Shestakova, M. V., Trubitsyna, N. P., Piletič, M., & Satman, İ. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.11.001 · Cited by 14
Disentangling True Determinants of Drug Therapy Effectiveness: A Double Fixed Effects Approach
Atella, V., Belotti, F., & Depalo, D. (2011) · Health Economics · doi:10.1002/hec.3570 · Cited by 16
Gatwood, J. D., Chisholm‐Burns, M. A., Davis, R. L., Thomas, F., Potukuchi, P. K., Hung, A. M., & Kovesdy, C. P. (2018) · Diabetic Medicine · doi:10.1111/dme.13775 · Cited by 14
Trief, P. M., Kalichman, S. C., Uschner, D., Tung, M., Drews, K. L., Anderson, B. J., Fette, L. M., Wen, H., Bulger, J., & Weinstock, R. S. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13431 · Cited by 18
Medication-taking beliefs and diabetes in American Samoa: a qualitative inquiry
Stewart, D. W., DePue, J. D., Rosen, R. K., Bereolos, N., Goldstein, M. G., Tuitele, J., Nu’usolia, O., & McGarvey, S. T. (2012) · Translational Behavioral Medicine · doi:10.1007/s13142-012-0114-y · Cited by 14
Chen, X. Z., Yu, S., Li, C., Zhan, X., & Yan, W. (2018) · Public Health · doi:10.1016/j.puhe.2018.06.016 · Cited by 14
Heinze, G., Jandeck, L. M., Hronský, M., Reichardt, B., Baumgärtel, C., Bucsics, A., Müllner, M., & Winkelmayer, W. C. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3898 · Cited by 15
The Management of Type 2 Diabetes Mellitus FOCUS on Quality
Miser, W. F. (2007) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.01.001 · Cited by 11
Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China
Gu, S., Zeng, Y., Yu, D. M., Hu, X., & Dong, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167190 · Cited by 13
Leggett, C., Giles, L. C., Anderson, J. J. A., Doogue, M. P., Couper, J., & Peña, A. S. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-316303 · Cited by 13
The Role of Occupational Therapy in Secondary Prevention of Diabetes
Shen, X., & Shen, X. (2019) · International Journal of Endocrinology · doi:10.1155/2019/3424727 · Cited by 14
Winkley, K., Upsher, R. J., Polonsky, W. H., & Holmes‐Truscott, E. (2019) · Diabetic Medicine · doi:10.1111/dme.14214 · Cited by 16
Diabetes Mellitus Versus Hypertension—Does Disease Affect Pharmacological Adherence?
Jankowska‐Polańska, B., Karniej, P., Polański, J., Seń, M., Świątoniowska-Lonc, N., & Grochans, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01157 · Cited by 13
Metadata
- Authors
- Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J.
- Affiliations
- Denver VA Medical Center (US)
- ORCID
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-09-25
- Volume
- 166
- Issue
- 17
- Pages
- 1836
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2156108549
- Cited by
- 1,135
- References
- 34
- Citations by year
- 2026: 15 · 2025: 38 · 2024: 41 · 2023: 57 · 2022: 49 · 2021: 60 · 2020: 58 · 2019: 63 · 2018: 76 · 2017: 63 · 2016: 81 · 2015: 75 · 2014: 93 · 2013: 60 · 2012: 75
- FWCI
- 23.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (K08-AG01011, K08AG001011)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- medication non-adherence, diabetes mellitus, hospitalization, all-cause mortality, proportion of days covered, oral hypoglycemics, antihypertensive drugs, statins, HbA1c, blood pressure, LDL cholesterol, managed care
- MeSH terms
- Administration, Oral, Aged, Antihypertensive Agents, Blood Pressure, Diabetes Mellitus, Female, Glycated Hemoglobin, Hospitalization, Humans, Hypoglycemic Agents, Cholesterol, LDL, Male, Middle Aged, Mortality, Retrospective Studies, Treatment Refusal, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review